esomeprazole vs risedronate

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of esomeprazole and risedronate. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Co-administration of risedronate sodium with the PPI, esomeprazole, increased risedronate bioavailability.

Drug Class
esomeprazole Proton Pump Inhibitor (PPI)
risedronate Bisphosphonate
Type
esomeprazole Over-the-Counter
risedronate Prescription
Summary
esomeprazole

Esomeprazole (Nexium) is a drug that reduces stomach acid. It belongs to a class of drugs called proton pump inhibitors (PPIs).

risedronate

Risedronate sodium delayed-release tablets help treat osteoporosis after menopause. It helps to make your bones stronger and less likely to break.

What It Treats
esomeprazole

This medicine treats frequent heartburn. Frequent heartburn means you have heartburn 2 or more days a week. This medicine is not for immediate relief of heartburn. It may take 1 to 4 days to work fully.

risedronate

This medicine treats osteoporosis in women after menopause. Osteoporosis makes bones weak and more likely to break. Risedronate can lower the chance of breaks in the spine and other bones.

How It Works
esomeprazole

Esomeprazole works by reducing the amount of acid your stomach makes. It blocks the proton pump in your stomach lining. This pump is responsible for producing stomach acid.

risedronate

Risedronate belongs to a class of drugs called bisphosphonates. It works by slowing down the breakdown of bone. This helps to increase bone density and reduce the risk of fractures.

Common Side Effects
esomeprazole
  • Nausea
  • Diarrhea
  • Headache
risedronate
  • Diarrhea
  • Flu-like symptoms
  • Joint pain
  • Back pain
  • Abdominal pain
FAERS Reports
esomeprazole
  • Chronic Kidney Disease 5,020
  • Acute Kidney Injury 4,563
  • Nausea 4,004
  • Diarrhoea 3,869
  • Fatigue 3,528
risedronate
  • Arthralgia 3,730
  • Pain 3,613
  • Nausea 2,991
  • Fatigue 2,911
  • Dyspnoea 2,802
Serious Warnings
esomeprazole

Do not take this medicine for more than 14 days, or more often than every 4 months, unless your doctor tells you to.

risedronate

Risedronate can cause problems with your esophagus. Follow the directions carefully and stay upright for 30 minutes after taking it. It can also cause bone, joint, or muscle pain. Tell your doctor right away if you have new pain in your thigh or groin.

Pregnancy
esomeprazole

Tell your doctor if you are pregnant or plan to become pregnant. Also, tell your doctor if you are breastfeeding or plan to breastfeed.

risedronate

Stop taking risedronate if you become pregnant. This medicine can affect the baby's bones. It is not known if risedronate passes into breast milk.

Also Compare, Nearby Drugs

How to Read This esomeprazole vs risedronate Comparison

esomeprazole is classified in the Proton Pump Inhibitor (PPI) drug class, while risedronate sits within the Bisphosphonate class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, esomeprazole has 20,984 submissions while risedronate has 16,047. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to this acid-reducing medicine can cause your body to absorb a larger amount of the bone medication than it normally would.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for esomeprazole or risedronate.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.